Ritonavir and metformin together efficiently inhibited important survival pathways in MM cells (KMS11, L363, and JJN3), such as the AKT and mTORC1 pathways that control the creation of Mcl-1 [87]. The gene discussed is MCL1; the disease is Miyoshi myopathy.